Literature DB >> 8205133

Drug absorption from large intestine: physicochemical factors governing drug absorption.

T Kimura1, K Sudo, Y Kanzaki, K Miki, Y Takeichi, Y Kurosaki, T Nakayama.   

Abstract

Profiles of absorption versus drug molecular weight and absorption versus drug lipophilicity were investigated in both the small and large intestines of rats by an in situ loop method. The absorption-molecular weight profiles examined using different-sized polyethylene glycols (PEGs) were different between the small and large intestines; the large-intestinal absorption of PEGs with molecular weights larger than 300 was poor, while PEGs with molecular weights up to 600 were relatively well absorbed in the small intestine. It is suggested that the paracellular route for drug penetration in the large intestine is restricted more than in the small intestine. The absorption-lipophilicity profiles were also examined in various regions (loops of 6 cm) of rat intestine using three acylsalicylic acids, acetyl-, propionyl- and butyrylsalicylic acids. The absorption rates of the acylsalicylic acids were different in the intestinal regions: the jejunum > the ileum > the colon > the rectum. In each region, the absorption rate increased with the drug lipophilicity. However, it was shown that the absorption rates in the small intestine tended to reach a ceiling at the high lipophilicity. To confirm this tendency, the absorption rates of acetaminophen and indomethacin were compared in the four intestinal regions. The absorption rates of highly lipophilic indomethacin were similar in the large and small intestines, while intermediately lipophilic acetaminophen was more rapidly absorbed in the small intestine than in the large intestine. A thicker unstirred water layer adjacent to the small-intestinal mucosa would be one of the factors which cause such varying absorption-lipophilicity profiles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205133     DOI: 10.1248/bpb.17.327

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES).

Authors:  Libo Yang; Shunsuke Watanabe; Jinhe Li; James S Chu; Musataka Katsuma; Shigeharu Yokohama; Joseph A Fix
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

2.  Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.

Authors:  N Katori; N Aoyagi; T Terao
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

3.  Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.

Authors:  M Shameem; N Katori; N Aoyagi; S Kojima
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

4.  Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.

Authors:  Dawn M George; Raymond J Huntley; Kevin Cusack; David B Duignan; Michael Hoemann; Jacqueline Loud; Regina Mario; Terry Melim; Kelly Mullen; Gagandeep Somal; Lu Wang; Jeremy J Edmunds
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

5.  Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults.

Authors:  Tao Liu; Jogarao V S Gobburu; Michelle D Po; Angus McLean; Norberto J DeSousa; Floyd R Sallee; Bev Incledon
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-02-27       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.